Transurethral plasmakinetic resection of prostate in high-risk benign prostatic hyperplasia patients: a multicenter prospective study

Objective To investigate the clinical efficacy of transurethral plasmakinetic resection of prostate (TUPKP) in treating high-risk benign prostatic hyperplasia (BPH) patients. Methods A prospective multicenter study design was employed. Patients with high-risk BPH treated with TUPKP were enrolled in...

Full description

Bibliographic Details

Published in:	Yixue xinzhi zazhi
Main Authors:	LI Fei, GENG Jie, CHEN Hongbo, ZHOU Zhijun, LIU Xiaohua, SHI Hongbo, DU Dan, ZHU Tao, ZHANG Jingyu, LI Xiaodong, QUE Hui, SONG Hongfei, YAO Qisheng, DOU  Zhongling, RUAN Jianzhong, ZHENG Jiang, ZHU Ziqing, REN Xuanyi, HUANG Qiao, GONG Kan, LIU Tongzu, HE Dalin, ZENG Xiantao
Format:	Article
Language:	Chinese
Published:	Editorial Office of New Medicine 2024-04-01
Subjects:	transurethral plasmakinetic resection of prostate benign prostatic hyperplasia high-risk patients cardiovascular diseases
Online Access:	https://yxxz.whuznhmedj.com/futureApi/storage/attach/2404/3MxdFmNVU7uJRX7LgAAs2CHGORB3xwJ7mDDkeRQS.pdf